Chiayi, Taiwan

Shang-Hong Chen

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Shang-Hong Chen

Introduction

Shang-Hong Chen is a notable inventor based in Chiayi, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for synthesizing important compounds. With a total of 3 patents to his name, Chen's work has had a meaningful impact on medical science.

Latest Patents

One of his latest patents is titled "Process for the production of Fondaparinux sodium." This invention provides improved methods for preparing Fondaparinux sodium by converting a compound of formula ABCDE4 at a reaction pH of no more than about 9.0. Additionally, the patent includes details on the intermediates used in the synthesis of Fondaparinux sodium. Another significant patent is "Process for preparing enzalutamide," which outlines an efficient process for the preparation of this important pharmaceutical compound.

Career Highlights

Shang-Hong Chen is currently associated with Scinopharm Taiwan, Ltd., where he continues to innovate and contribute to the pharmaceutical industry. His expertise in chemical processes has positioned him as a valuable asset in his field.

Collaborations

Chen has worked alongside talented colleagues such as Wen-Li Shih and Yuan-Xiu Liao, contributing to a collaborative environment that fosters innovation and advancement in pharmaceutical research.

Conclusion

Shang-Hong Chen's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work continues to influence the development of important therapeutic compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…